Citations

Clear

381 citation(s) found for "Gross, M".

Stereotactic radiosurgery versus observation for intracranial low-grade dural arteriovenous fistulas
Becerril‐Gaitan, Andrea , Peesh, Pedram , Liu, Collin, Lee, Cheng-chia, Niranjan, Ajay , Lunsford, L. Dade , Wei, Zhishuo , Hoang, A, Sheehan, Jason P. , Dayawansa, Sam , Samanci, Yavuz, Starke, Robert M. , Ikeda, Go , Kano, Hideyuki , Wang, Qian , Welch, Babu G. , O’Con, Jennifer, Lanzino, Guiseppe, Brinjikji, Waleed , Hayakawa, M. , Gross, Bradley A. , Albuquerque, Felipe C , Lawton, Michael T., Kim, Louis J. , Alaraj, Ali , Winkler, Ethan A. , Chalouhi, Nohra , Bulters, Diederik , Durnford, Andrew , Satomi, Junichiro, Tada, Yoshiteru , Dijk, J. Marc C. van , Potgieser, Adriaan R. E., Laurent, Dimitri , Bahmani, Brigette, Zipfel, Gregory J. , Samancı, Yavuz , Tripathi, Manjul , Welch, Babu , Du, Rose , Lai, Rosalind , Gross, Bradley , Levitt, Michael R , Alaraj, Ali , van DijK, J Marc C , Osbun, Joshua W , Bulters, Diederik O , Yang, Huai‐Che , Peker, Selçuk , Abdelsalam, Ahmed , Kondziolka, Douglas , Bernstein, Kenneth, Ming, Ying, Liščák, Roman , May, Jaromír , Li, Wen , O’Con, Jennifer, Amin-Hanjani, Sepideh , Nguyen, Quang, Samaniego, Edgar A , Lai, Pui Man Rosalind , Derdeyn, Colin P. , Abla, Adib A. , Lawton, Michael T. , Kim, Louis J. , Levitt, Michael R. , Hoh, Brian L. , Chen, Ching‐Jen

Mayo Clinic

Journal of Neurology, Neurosurgery & Psychiatry | June 6, 2025 | Volume: 96 | Issue: 11 | Pages: 1117-1125

10.1136/jnnp-2024-335675 | PMID 40480804 Get It

Background Given the low haemorrhagic risk of intracranial low-grade dural arteriovenous fistulas (dAVFs), the benefits of routine intervention remain controversial. This study compares patient outcomes treated with stereotactic radiosurgery (SRS) versus conservative management. Method Multicentre retrospective analysis of the Consortium for Dural Arteriovenous Fistula Outcomes Research and the International Radiosurgery Research Foundation data. Inclusion criteria were (1) intracranial low-grade dAVF diagnosed by catheter-based angiography, (2) no prior dAVF-related haemorrhage and (3) management with upfront SRS (intervention group) or conservative management (observation group). The primary outcome was symptomatic improvement. Secondary outcomes included dAVF obliteration, up-conversion, haemorrhage, improvement and favourable modified Rankin Scale (mRS) at follow-up. Results 304 patients with a mean age of 56 years (SD 13.5) and a follow-up of 46.7 months (SD 45.5) were included. 135 (44.4%) were managed conservatively and 169 (55.6%) had upfront SRS. Compared with the observation group, symptomatic and mRS Score improvement (≥1-point decrease in baseline score) was more likely in the intervention group (95.1% vs 58.5%; OR=13.75 (5.61–33.69) and 37.0% vs 24.0%; OR=1.85 (1.09–3.15), respectively). These findings remained significant after multiple imputation and propensity score matching. Remaining outcomes were similar between groups. The all-cause mortality rate was 5.4% (n=16), unrelated to the dAVF or treatment. Five (3.0%) SRS-related complications were reported and resolved during the follow-up period. Conclusions SRS was associated with increased symptomatic and mRS Score improvement for low-grade dAVFs compared with conservative management. SRS had a low complication risk and did not appear to alter dAVF obliteration or haemorrhage. Future prospective trials on SRS as a first-line intervention for symptomatic low-grade dAVFs should be considered.
Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia
Pike, James Russell , Lutsey, Pamela L. , Palta, Priya , Windham, B. Gwen , Bandeen‐Roche, Karen , Coresh, Josef, Sharrett, A. Richey , Gross, Alden L. , Lutsey, Pamela L , Pike, James R , Smith, Jason R. , Gottesman, Rebecca F. , Knopman, David S. , Selvin, Elizabeth , Szklo, Moysés , Deal, Jennifer A.

Mayo Clinic

JAMA Neurology | June 2, 2025 | Volume: 82 | Issue: 7 | Pages: 644

10.1001/jamaneurol.2025.1495 | PMID 40455489 Get It

ImportanceMidlife vascular risk factors are associated with an elevated risk of dementia. However, the total contribution of vascular risk factors in midlife and late life with incident dementia is uncertain.ObjectiveTo quantify the proportion of incident dementia attributable to modifiable vascular risk factors measured in midlife and late life and to examine differences by apolipoprotein ε4 genotype, self-reported race, and sex.Design, Setting, and ParticipantsThis was a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study using 33 years of follow-up (1987-2020). The setting included ARIC field centers (Jackson, Mississippi; Forsyth County, North Carolina; Minneapolis suburbs, Minnesota; Washington County, Maryland). Study baseline in Black and White participants with complete exposure and covariate data was set by age at risk factor measurement (45-54 years, 55-64 years, and 65-74 years). Data were analyzed from August 2023 to December 2024.ExposuresHypertension (systolic blood pressure [BP] ≥130 mm Hg, diastolic BP ≥80 mm Hg, or use of medication for BP), diabetes (fasting glucose ≥126 mg/dL, nonfasting glucose ≥200 mg/dL, self-reported physician’s diagnosis, or use of any diabetes medication), and current smoking (self-reported).Main Outcomes and MeasuresIncident dementia. Population attributable fractions were estimated by age 80 years, and separately after 80 years, from having at least 1 vascular risk factor by age at risk factor measurement.ResultsA total of 7731 participants were included in analysis of risk factors measured at age 45 to 54 years (4494 female [58%]; 2207 Black [29%]; 5524 White [71%]), 12 274 contributed to analysis of risk factors measured at age 55 to 64 years (6698 female [55%]; 2886 Black [24%]; 9388 White [76%]), and 6787 contributed to analysis of risk factors measured at age 65 to 74 years (3764 female [56%], 1375 Black [20%]; 5412 White [80%]). There were 801, 995, and 422 dementia cases by 80 years, respectively. The fraction of dementia by 80 years attributable to at least 1 vascular factor at age 45 to 54 years was 21.8% (95% CI, 14.3%-29.3%), at 55 to 64 years was 26.4% (95% CI, 19.1%-33.6%), and at 65 to 74 years was 44.0% (95% CI, 30.9%-57.2%). Attributable fractions for these factors were higher in apolipoprotein ε4 noncarriers at age 55 years and older (range, 33.3%-61.4%), Black individuals at age 45 years and older (range, 25.5%-52.9%), and female individuals at age 55 years and older (range, 29.2%-51.3%). Only 2% to 8% of dementia cases after 80 years were attributable to these factors.Conclusions and RelevanceResults of this cohort study suggest that between 22% and 44% of incident dementia cases by 80 years in the ARIC study were attributed to midlife and late-life vascular risk factors. Assuming causal relationships, maintaining optimal vascular health across the life course could mitigate a sizeable proportion of dementia risk by 80 years.
The fetal myocardial fulcrum: echocardiographic study, functional evaluation, gross anatomy and histology
Olavarría, Alberto Sosa , Yániz, Reigosa, Peña, Martí, Peralta, Zurita, Giugni, Schenone, Ramírez, Alcedo, Peña, Martí, Ramírez, Alcedo

Mayo Clinic

No container title available | April 26, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.174565465.58761923/v1 Get It

Objective: The fulcrum as a structure that has been described in human and mammalian hearts as ossa cordis; the aim of the present study is to demonstrate its existence in the fetal heart, using ultrasonographic techniques and macro and microscopic anatomy. Methods: Ultrasound images of the fulcrum were obtained in 240 normal fetal hearts between 26 and 37 weeks of gestation, using 2D ultrasound and TM mode in 201 cases. Speckle tracking alone was used in 58 cases to demonstrate the triphasic movements of the fulcrum. Macroscopic anatomical dissection and histological study were performed in eight fetal hearts from spontaneous abortions (20-22 weeks). Results: We demonstrated the presence of the cardiac fulcrum, on which myocardial tissue fibers are inserted as a tendon constituting a unit that serves as a pivot for cardiac contraction, resulting in a three-phase displacement of the fulcrum. Values and displacement curves were obtained as a function of gestational age, adjusted to the cubic regression model and bivariate correlation (p < 0.001). Macroscopic anatomy and histology results are presented. Conclusions: The present study demonstrated the myocardial fulcrum in the fetal heart, a structure composed of myxo-chondroid tissue, being able to be visualized by ultrasound. This structure that acts as a lever has a mixed displacement that can be quantified in terms of vertical, rotational, angular and deformation displacement. Its existence could be proved in macro and histological dissections demonstrating the anchorage of cardiac fibers at the ends of this structure.
Prostate-Specific Membrane Antigen Imaging Findings and Subsequent Clinical Management Among Patients With Biochemically Recurrent Prostate Cancer
Rabil, Maximilian , Ghaffar, Umar , Long, Jessica B., Sprenkle, Preston C. , Kim, Isaac Yi , Saperstein, Lawrence, Wang, Shi‐Yi , Ma, Xiaomei , Gross, Cary P. , Karnes, R. Jeffrey , Wang, Shi-Yi , Ma, Xiaomei , Westvold, Sarah J. , Kunst, Natalia , Leapman, Michael

Mayo Clinic

JU Open Plus | April 22, 2025 | Volume: 3 | Issue: 4 | Pages: No page available

10.1097/ju9.0000000000000278 Get It

Purpose: Prostate-specific membrane antigen positron emission tomography (PSMA-PET) improves prostate cancer (PCa) localization, particularly in biochemical recurrence (BCR). The primary objective was to assess management patterns after PSMA-PET for BCR at 2 academic centers. Methods: This study evaluated clinical management within 6 months after first PSMA-PET for patients with BCR after local therapy. Management categories included no treatment, local therapy, systemic therapy, and metastasis-directed therapy (MDT). We also evaluated clinical management decision variation across strata of PSMA-PET results PSA levels (<2.0, 2.0-4.99, and ≥5.0 ng/mL) at time of imaging. Results: We identified 581 patients who received PSMA-PET from February 2021 to June 2023. PSMA-PET findings were negative in 142 (24%) and demonstrated localized recurrence in 86 (15%), regional nodal disease in 60 (10%), and distant metastasis in 293 (50%). Distant metastasis was identified in 105 (35%) patients with PSA < 2.0, 67 (60%) with PSA 2.0 to 4.99, and 115 (71%) with PSA ≥ 5.0. In patients with negative PSMA-PET, 63 (44%) received treatment. Conversely, 92% with detected metastases were treated (systemic therapy in 189 [64%], MDT in 75 [26%], and local therapy in 7 [2%]). Treatments differed by the PSA level within strata of PSMA-PET findings. Among 293 patients with metastases, MDT was used more commonly in patients with PSA < 2.0 (37%) than PSA 2.0 to 4.99 (30%) or PSA ≥ 5.0 (13%). Conclusions: Most patients undergoing PSMA-PET for BCR had identifiable disease and initiated therapy within 6 months. Identification of distant metastases and treatment choices differed by the PSA level at imaging. Prospective research is needed to determine whether earlier detection and treatment initiation improve clinical outcomes.
Abstract P2098: The Interaction of Vascular Risk Factors in Midlife and Late-life on Incident Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study
Gottesman, Rebecca F., Palta, Priya , Windham, B. Gwen , Coresh, Josef, Sharrett, A. Richey , Gross, Alden L. , Smith, Jason A. , Pike, James Russell , Lutsey, Pamela L. , Selvin, Elizabeth , Knopman, David S. , Deal, Jennifer A.

Mayo Clinic

Circulation | April 17, 2025 | Volume: 151 | Issue: Suppl_1 | Pages: No page available

10.1161/cir.151.suppl_1.p2098 Get It

Introduction: Vascular risk factors of hypertension, diabetes, and smoking in midlife (45-64 years) and possibly early late-life (65-74 years) are associated with increased risk of dementia. Current estimates of population attributable risk for dementia assume vascular factors are independent and do not interact to increase risk of dementia, which may underestimate the combined impact of vascular risk reduction on dementia incidence. In this study, we evaluated the joint association and interaction of vascular risk factors on risk of dementia. Methods: We performed a prospective cohort analysis using the Atherosclerosis Risk in Communities Neurocognitive Study using up to 33 years of follow-up (1987-2020). We used age as baseline (45-54 years, n=7,731; 55-64 years, n=12,273; and 65-74 years, n=6,660). We defined hypertension as systolic blood pressure ≥130 mm Hg, diastolic blood pressure ≥80 mm Hg, or anti-hypertension medication use. We defined diabetes as fasting glucose level ≥126 mg/dL, non-fasting glucose ≥200 mg/dL, self-reported physician diagnosis, or use of any diabetes medication. Current smoking was self-reported. We investigated additive and multiplicative interactions for combinations of vascular risk factors on incident (adjudicated) dementia by age 80 using joint effect variables in Cox regression models stratified by age of risk factor measurement (45-54 years, 55-64 years, or 65-74 years). For interaction analyses, parameter values >1 indicate positive interaction (synergy) and values <1 indicate negative interaction (antagonism). Results: In participants with risk factors measured in these baseline age strata, there were 801 (10%), 995 (8%), and 422 (6%) cases of incident dementia by age 80, respectively. Hypertension and diabetes exhibited positive interactions on the additive and multiplicative scales in midlife (Figure 1). Diabetes and smoking in midlife had positive additive interaction (value >1, Figure 2). All vascular risk factor combinations in late-life had negative interactions on the multiplicative scale (values <1, Figures 1-3). Conclusions: Hypertension with diabetes and diabetes with smoking, all measured in midlife, interact to increase risk of dementia by age 80. The overall impact of reducing midlife vascular risk factors on incident dementia could be sizeable. These findings highlight the importance of multifactor interventions addressing combinations of vascular risk factors for dementia prevention strategies.
Burnout and career satisfaction among urologists specializing in sexual health
Schrup, Sarah E. , Hanley, Meg , May, Emily , Jones, James M. , Ziegelmann, Matthew , Gross, Martin , Schrup, Sarah, Jones, James M

Mayo Clinic

The Journal of Sexual Medicine | April 15, 2025 | Volume: 22 | Issue: 5 | Pages: 869-876

10.1093/jsxmed/qdaf074 | PMID 40231422 Get It

Abstract Background While the rate of physician burnout has been characterized as relatively high among urologists compared to other specialties, a specific examination of burnout and predictors of burnout among urologists specializing in sexual medicine has not been conducted. Aim The aim of this study was to collect demographic characteristics of urologists specializing in sexual medicine, assess the occurrence of and risk factors for burnout, and characterize satisfaction with career, compensation and work-life balance. Methods We surveyed 96 urologists specializing in sexual medicine to characterize demographic and practice characteristics and assess their satisfaction with career aspects and levels of burnout. Univariable and multivariable modeling with stepwise variable selection was utilized to identify predictive variables of burnout. Outcomes The Copenhagen Burnout Inventory was used to assess personal burnout, work-related burnout, patient-related burnout, and overall burnout. Results Twenty-four percent (n = 23) of participants reported burnout with 35.4% (n = 34) reporting personal burnout, 38.5% (n = 37) reporting work-related burnout, and 24.0% (n = 23) reporting patient-related burnout. Younger age (P = 0.051), Black/African American or multiracial race compared to white race (P &lt; 0.0001), Latino or Hispanic background (P = 0.034), female sex (P = 0.059), being unmarried (P = 0.047), and increased educational debt (0.030) were identified as predictive of overall burnout in adjusted analysis. Dissatisfaction with work-life balance was significantly related to an increase in all categories of burnout (P &lt; 0.01). Clinical implications These findings may guide practice patterns and initiatives to support groups identified at increased risk of burnout, as well as function as a benchmark for future studies of burnout in the sexual medicine urology community. Strengths and limitations While this is the first study of burnout specifically among sexual medicine urologists and findings are consistent with the overall urology community, the small sample size may lead to a biased sample. Conclusion Several demographic and personal characteristics were identified to be predictive of burnout among the sexual medicine urology community, indicating opportunities for additional support.
Approaches to Timescale Choice in Cognitive Aging Research and Potential Implications for Estimated Exposure Effects: Coordinated Analyses in 10 Cohorts of Older Adults
Hayes‐Larson, Eleanor , Andrews, Ryan M. , Kezios, Katrina , Bercu, Ariane, Rouanet, Anaïs , Helmer, Catherine , Crane, Paul K. , Klinedinst, Brandon S. , McEvoy, Linda K. , Weuve, Jennifer , Rajan, Kumar B. , Shaw, Crystal , Sims, Kendra D. , Therneau, Terry M. , Petersen, Ronald C., Bouteloup, Vincent , Gross, Alden L. , Albert, Marilyn, Morris, John C., Resnick, Susan M. , Turney, Indira C. , Vonk, Jet M. J. , Avila‐Rieger, Justina , Weigand, Alexandra J. , Chen, Ruijia , Wang, Jingxuan , Mayeda, Elizabeth Rose , Klinedinst, Brandon S , McEvoy, Linda K , Weuve, Jennifer , Mez, Jesse , Sims, Kendra D , Therneau, Terry , Albert, Marilyn S. , Masters, Colin L , Resnick, Susan M , Maruff, Paul , Manly, Jennifer J , Turney, Indira C , Vonk, Jet M J , Avila-Rieger, Justina , Weigand, Alexandra , Mayeda, Elizabeth Rose , Gibbons, Laura E. , Nichols, Emma , Rajan, Kumar Bharat , Hwang, Phillip H , Mez, Jesse , Farina, Mateo P. , Morris, John C. , Masters, Colin L. , Maruff, Paul , Manly, Jennifer J. , Proust‐Lima, Cécile

Mayo Clinic

Epidemiology | March 31, 2025 | Volume: 36 | Issue: 4 | Pages: 560-571

10.1097/ede.0000000000001859 | PMID 40164562 Get It

Background: Cognitive change is an important factor in understanding dementia. Estimating effects of exposures on cognitive change requires choosing an analytical timescale, typically time on study or current age. There is limited consensus regarding timescale choice in epidemiologic cognitive aging research. Methods: Using a coordinated analytic approach in 10 cohorts of older adults, we evaluated whether estimated effects of two exposures on memory change differed depending on timescale (time on study or current age). We modeled effects of apolipoprotein-E (APOE) ε4 genotype (a time-invariant exposure) and diabetes (a potentially time-varying/acquired exposure evaluated at baseline) using mixed-effects models with linear and nonlinear time specifications for both timescales. Results: Among APOE ε4 carriers, model-estimated memory scores at baseline (time on study timescale) or at each cohort’s median baseline age (current age timescale) were lower, and the average rate of decline was faster than among APOE ε4 noncarriers. Model-estimated memory scores at baseline or at median baseline age were generally similar across baseline diabetes status, with variability across cohorts in the diabetes-memory change association. In some cohorts, trends in diabetes-memory change associations differed in direction across timescales. Conclusions: Timescale was largely inconsequential for estimated effects of APOE genotype, but yielded differences in estimated diabetes effects, raising questions about the appropriate scale. The current age scale may be problematic because diabetes was measured heterogeneously in age across individuals, a common issue in aging cohorts. Our work demonstrates approaches to evaluate alternative timescales, including in multicohort analyses, and highlights potential implications for estimated exposure effects on cognitive change.
MRI-Negative Cushing’s Disease: Subtotal Gland Resection versus Gross Total Resection to Preserve Pituitary Gland Function
Erickson, Dana , Henderson, J. Michael, Palit, Sandhya R. , Shinya, Yuki , Bancos, Irina , Henderson, Justine S., Hong, Sukwoo , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 7, 2025 | Volume: 86 | Issue: No issue available | Pages: No page available

10.1055/s-0045-1803043 Get It

The combined impact of midlife and late‐life vascular risk factors on 33‐year incident dementia: the Atherosclerosis Risk in Communities Study
Palta, Priya, Windham, B. Gwen, Coresh, Josef, Sharrett, Richey, Gross, Alden L. , Smith, Jason R. , Pike, James Russell , Selvin, Elizabeth , Lutsey, Pamela L. , Knopman, David S. , Deal, Jennifer A.

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S7 | Pages: No page available

10.1002/alz.084043 Get It

AbstractBackgroundMidlife vascular risk factors are associated with an increased risk of dementia. However, the overall contribution of modifiable vascular risk factors in midlife and late‐life to dementia remains unclear. In this study, we quantified population attributable fractions, which account for risk factor prevalence and strength of relative risks, of incident dementia from vascular risk factors measured in midlife and early late‐life.MethodWe used 33 years of prospective cohort data in the Atherosclerosis Risk in Communities Study. Incident dementia (community surveillance and algorithmic diagnosis with expert clinical adjudication) was ascertained from baseline (1987‐1989) through December 31, 2020. We quantified population attributable fractions of incident dementia by age 80 from the combination of hypertension (systolic blood pressure ≥130, diastolic blood pressure ≥80, or use of medication), diabetes (fasting glucose ≥126, non‐fasting glucose ≥200, self‐reported physician diagnosis of diabetes, or use of medication for diabetes/insulin), and self‐reported current cigarette smoking (at least one risk factor versus none) measured at different ages (45‐54 [n = 7,731], 55‐64 [n = 12,273]; 65‐74 [n = 6,660]). We also computed attributable fractions stratified by sex, apolipoprotein ε4 genotype, and self‐reported race.ResultThe prevalence of having one or more of the vascular risk factors was 61.6% (95% CI: 60.5, 62.7%) at age 45‐54 and increased to 77.5% (95% CI: 76.5, 78.5%) by age 65‐74. Population attributable fractions of dementia increased from 22.7% (95% CI: 15.3, 30.1%) for vascular risk factors measured at age 45‐54 to 45.4% (95% CI: 32.5, 58.3%) for vascular risk factors assessed at age 65‐74 (see Figure). Attributable fractions were larger in females, participants without apolipoprotein ε4 alleles, and Black participants (Figure).ConclusionBetween 23% to 45% of incident dementia cases by age 80 were attributed to a combination of hypertension, diabetes, or current smoking up through age 74. Attributable fractions for the combined impact of vascular risk varied by key demographics. Public health strategies targeting modifiable vascular risk factors could reduce dementia risk and increase healthy lifespan.
Ethical Use of Cadaveric Images in Anatomical Textbooks, Atlases, and Journals: A Consensus Response From Authors and Editors
Kim, Hee‐Jin , Logan, Bari M., Hutchings, R. T., Anand, Mahindra , Burns, Danny, Singh, Vishram, Peris‐Celda, Maria , Martı́nez-Soriano, Francisco, Apaydın, Nihal, Hanna, Amgad S. , Yoshioka, Nobutaka , Fernandez‐Miranda, Juan C. , Saremi, Farhood , Spratt, Jonathan D., Ho, Siew Yen , Mori, Shumpei , Komune, Noritaka , Watanabe, Koichi , Abrahams, Peter, Ibaragi, Soichiro , Loukas, Marios , Tubbs, R. Shane, Kim, Hee-Jin , Hur, Mi-Sun , Reina, Francisco , Tabira, Yoko , Carrera, Anna , Komune, Noritaka , Watanabe, Koichi , Reina, Miguel Angel , Loukas, Marios , Iwanaga, Joe , Akita, Keiichi , Ottone, Nicolás Ernesto , Nonaka, Yoichi , Shoja, Mohammadali M. , Tabira, Yoko , Prats‐Galino, Alberto , Andrés, José De , Reina, Miguel Ángel , Anderson, Robert Henry

Mayo Clinic

Clinical Anatomy | January 4, 2025 | Volume: 38 | Issue: 2 | Pages: 222-225

10.1002/ca.24258 | PMID 39754475 Get It

ABSTRACT Nowadays, consent to use donor bodies for medical education and research is obtained from the body donors and their families before the donation. Recently, the International Federation of Associations of Anatomists (IFAA) published guidelines that could restrict the appearance of cadaveric images in commercial anatomical resources such as textbooks and other educational products. These guidelines state that the donor must expressly consent to using such images for this purpose. Cadaveric photos and drawings made from dissections of cadavers have been used in anatomy textbooks and atlases for hundreds of years. They are invaluable for anatomy students and clinical/surgical practitioners. The IFAA guidelines should not restrict the use of those older books; to do so would infringe the rights of those seeking knowledge from these resources. As the images in such textbooks and atlases are anonymized and are used for teaching and research, and the donors and their families are informed about this before the donation, we believe no additional consent is needed. It is impossible to separate educational from “commercial” usage entirely in any situation, e.g., publications from publishers and the use of cadavers in medical schools. Therefore, our best efforts to avoid unethical use of cadaveric images by following traditional consent processes are still needed so that more people will reap the benefits from them. As senior textbook/atlas authors/editors from over 10 countries, we believe that using cadaveric images in anatomy textbooks is appropriate, and no additional consent should be necessary. Such usage falls within the good faith of professionals using these invaluable gifts.